Jin Yang Pharmaceutical Statistics

Total Valuation

Jin Yang Pharmaceutical has a market cap or net worth of KRW 67.65 billion. The enterprise value is 149.29 billion.

Market Cap	67.65B
Enterprise Value	149.29B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Jin Yang Pharmaceutical has 11.35 million shares outstanding. The number of shares has increased by 0.93% in one year.

Current Share Class	n/a
Shares Outstanding	11.35M
Shares Change (YoY)	+0.93%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	31.83%
Owned by Institutions (%)	0.00%
Float	7.74M

Valuation Ratios

The trailing PE ratio is 2.74.

PE Ratio	2.74
Forward PE	n/a
PS Ratio	0.58
PB Ratio	0.56
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.67, with an EV/FCF ratio of -2.00.

EV / Earnings	5.31
EV / Sales	1.34
EV / EBITDA	14.67
EV / EBIT	19.62
EV / FCF	-2.00

Financial Position

The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.73.

Current Ratio	2.11
Quick Ratio	1.33
Debt / Equity	0.73
Debt / EBITDA	8.43
Debt / FCF	-1.15
Interest Coverage	4.58

Financial Efficiency

Return on equity (ROE) is 27.51% and return on invested capital (ROIC) is 3.07%.

Return on Equity (ROE)	27.51%
Return on Assets (ROA)	2.71%
Return on Capital (ROIC)	3.07%
Revenue Per Employee	505.22M
Profits Per Employee	127.87M
Employee Count	220
Asset Turnover	0.63
Inventory Turnover	2.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-9.17%
50-Day Moving Average	5,480.20
200-Day Moving Average	5,604.35
Relative Strength Index (RSI)	59.01
Average Volume (20 Days)	1,084,408

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jin Yang Pharmaceutical had revenue of KRW 111.15 billion and earned 28.13 billion in profits. Earnings per share was 2,175.73.

Revenue	111.15B
Gross Profit	68.23B
Operating Income	7.61B
Pretax Income	35.22B
Net Income	28.13B
EBITDA	10.18B
EBIT	7.61B
Earnings Per Share (EPS)	2,175.73

Full Income Statement

Balance Sheet

The company has 4.16 billion in cash and 85.80 billion in debt, giving a net cash position of -81.65 billion or -7,193.16 per share.

Cash & Cash Equivalents	4.16B
Total Debt	85.80B
Net Cash	-81.65B
Net Cash Per Share	-7,193.16
Equity (Book Value)	118.02B
Book Value Per Share	10,655.39
Working Capital	23.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 15.66 billion and capital expenditures -90.36 billion, giving a free cash flow of -74.70 billion.

Operating Cash Flow	15.66B
Capital Expenditures	-90.36B
Free Cash Flow	-74.70B
FCF Per Share	-6,581.14

Full Cash Flow Statement

Margins

Gross margin is 61.39%, with operating and profit margins of 6.85% and 25.31%.

Gross Margin	61.39%
Operating Margin	6.85%
Pretax Margin	31.69%
Profit Margin	25.31%
EBITDA Margin	9.16%
EBIT Margin	6.85%
FCF Margin	-67.21%

Dividends & Yields

This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 2.70%.

Dividend Per Share	150.00
Dividend Yield	2.70%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	5.75%
Buyback Yield	-0.93%
Shareholder Yield	1.77%
Earnings Yield	36.51%
FCF Yield	-110.42%

Dividend Details

Stock Splits

The last stock split was on April 21, 2005. It was a forward split with a ratio of 10.

Last Split Date	Apr 21, 2005
Split Type	Forward
Split Ratio	10

Scores

Jin Yang Pharmaceutical has an Altman Z-Score of 1.6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.6
Piotroski F-Score	n/a